Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug:222:104-112.
doi: 10.1016/j.schres.2020.04.019. Epub 2020 Jun 7.

A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis

Affiliations
Review

A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis

Gregory P Strauss et al. Schizophr Res. 2020 Aug.

Abstract

Studies attempting to deconstruct the heterogeneity of schizophrenia and the attenuated psychosis syndrome consistently find that negative symptoms are a core dimension that is distinct from other aspects of the illness (e.g., positive and disorganized symptoms). Negative symptoms are also highly predictive of poor community-based functional outcomes, suggesting they are a critical treatment target. Unfortunately, pharmacological and psychosocial treatments for negative symptoms have demonstrated limited effectiveness. To address this critical unmet therapeutic need, the NIMH sponsored a consensus development conference to delineate research priorities for the field and stimulate treatment development. A primary conclusion of this meeting was that next-generation negative symptom rating scales should be developed to address methodological and conceptual limitations of existing instruments. Although second-generation rating scales were developed for adults with schizophrenia, progress in this area has lagged behind for youth at clinical-high risk (CHR) for developing psychosis (i.e. those meeting criteria for a prodromal syndrome). Given that negative symptoms are highly predictive of the transition to diagnosable psychotic illness, enhancing our ability to detect negative symptoms in CHR youth is paramount. The current paper discusses conceptual and methodological limitations inherent to existing scales that assess negative symptoms in CHR youth. The theoretical and clinical implications of these limitations are evaluated. It is concluded that new scales specifically designed to assess negative symptoms in CHR youth are needed to accurately chart mental illness trajectories and determine when, where, and how to intervene. Recent efforts to develop next-generation measures designed specifically for CHR youth to meet this urgent need in the field are discussed. These new approaches offer significant progress for addressing issues inherent to earlier scales.

Keywords: Alogia; Anhedonia; Asociality; Avolition; Blunted affect; Prodrome.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest G.P.S. is one of the original developers of the Brief Negative Symptom Scale (BNSS) and receives royalties and consultation fees from Medavante-ProPhase LLC in connection with commercial use of the BNSS and other professional activities; these fees are donated to the Brain and Behavior Research Foundation. GPS has received honoraria and travel support from Medavante-ProPhase LLC for training pharmaceutical company raters on the BNSS. In the past 2 years, GPS has consulted for and/or been on the speaker bureau for Minerva Neurosciences, Acadia, and Lundbeck pharmaceutical companies. VAM, APB, KFV, and EFW have no relevant disclosures to report.

Republished in

References

    1. Addington J, Cornblatt B, Cadenhead K, Cannon T, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, 2011. At clinical high risk for psychosis: outcome for nonconverters. Am. J. Psychiatry 168(8), 800–805. - PMC - PubMed
    1. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, … & Tsuang MT (2017). Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophrenia research, 190, 90–95.). - PMC - PubMed
    1. Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Strauss GP 2019. Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr. Bull 45(2), 305–314. - PMC - PubMed
    1. Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW. Negative symptoms and impaired social functioning predict later psychosis in L atino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early intervention in psychiatry. 2015;9(6):467–75. - PMC - PubMed
    1. American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub.

Publication types